Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma

被引:40
|
作者
Wu, CF
Shee, JJ
Ho, DR
Chen, WC
Chen, CS
机构
[1] Chang Gung Mem Hosp, Dept Surg, Div Urol, Chiayi 613, Taiwan
[2] Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan
关键词
kidney; carcinoma; transitional cell; dialysis; urinary tract;
D O I
10.1097/01.ju.0000101758.41635.28
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Transitional cell carcinoma is the most common urinary tract cancer in Taiwanese patients on dialysis. It is a unique finding compared within Western countries. Due to this geographic difference and a higher recurrence rate a more extensive operation and aggressive followup protocols should be refined for these patients on dialysis. Materials and Methods: We retrospectively reviewed the medical records of all patients with transitional cell carcinoma who had end stage renal disease and underwent hemodialysis. Records were reviewed for hemodialysis duration, initial tumor location, tumor grade, stage, operative method, operative complication and final surgical status. Tumor grade and stage was determined by the WHO and proposed Jewett systems. Six patient groups were classified according to final surgical status for comparative analysis. Results: A total of 30 patients were included in this study. Painless gross hematuria and urethral bloody discharge were the most common complaints. Tumor in 25 of the 30 cases was high grade and all were early stage. Of the patients 11 (36.7%) had undergone bilateral nephroureterectomy and radical cystectomy in as a 1 or multiple step procedure. Six patients (20%) had undergone bilateral nephroureterectomy at 1 or 2 sequential operations. Seven of the 13 patients (53.8%) in whom low urinary tract transitional cell carcinoma was initially treated with transurethral resection unfortunately had recurrent transitional cell carcinoma of the upper urinary tract. Ten of the 14 patients (71.4%) with upper urinary tract transitional cell carcinoma who underwent nephroureterectomy and bladder cuff excision had subsequent transitional cell carcinoma within the bladder. Conclusions: Patients with transitional cell carcinoma on dialysis had a higher recurrence rate in the upper urinary tract than patients not on dialysis. Most cases were at an early stage but with high grade tumor behavior. In 11 patients (36.7%) total exenteration of the urinary tract except the urethra was eventually done. The final bilateral nephroureterectomy rate was 56.7%. Since the rate of total exenteration and bilateral nephrectomy was abnormally high at such a short followup, 1-step bilateral nephroureterectomy and radical cystectomy are a recommended treatment for patients with transitional cell carcinoma on dialysis.
引用
收藏
页码:126 / 129
页数:4
相关论文
共 50 条
  • [1] High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease
    Wang, Tsung-Yang
    Hu, Chia-Jung
    Kuo, Chin-Wei
    Chen, Yu
    Lin, Ja-Liang
    Yang, Chih-Wei
    Yen, Tzung-Hai
    NEPHROLOGY, 2011, 16 (02) : 225 - 231
  • [2] Renal cell carcinoma and end stage renal disease
    Farivar-Mohseni, Hesam
    Perlmutter, Adam E.
    Wilson, Shandra
    Shingleton, W. Bruce
    Bigler, Steven A.
    Fowler, Jackson E., Jr.
    JOURNAL OF UROLOGY, 2006, 175 (06) : 2018 - 2020
  • [3] Genomic profiling of renal cell carcinoma in patients with end-stage renal disease
    Inoue, Toru
    Matsuura, Keiko
    Yoshimoto, Taichiro
    Lam Tung Nguyen
    Tsukamoto, Yoshiyuki
    Nakada, Chisato
    Hijiya, Naoki
    Narimatsu, Takahiro
    Nomura, Takeo
    Sato, Fuminori
    Nagashima, Yoji
    Kashima, Kenji
    Hatakeyama, Shingo
    Ohyama, Chikara
    Numakura, Kazuyuki
    Habuchi, Tomonori
    Nakagawa, Masayuki
    Seto, Masao
    Mimata, Hiromitsu
    Moriyama, Masatsugu
    CANCER SCIENCE, 2012, 103 (03) : 569 - 576
  • [4] Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis
    Park, Chi Young
    ANTI-CANCER DRUGS, 2009, 20 (09) : 848 - 849
  • [5] Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis
    Shrewsberry, Adam B.
    Osunkoya, Adeboye O.
    Jiang, Kun
    Westby, Ruth
    Canter, Daniel
    Pattaras, John
    Turgeon, Nicole
    Master, Viraj A.
    Ogan, Kenneth
    CLINICAL TRANSPLANTATION, 2014, 28 (02) : 211 - 216
  • [6] Assessment of Quality of Life in Patients of End Stage Renal Disease on Different Modalities of Treatment
    Shrestha, S.
    Ghotekar, L. R.
    Sharma, S. K.
    Shangwa, P. M.
    Karki, P.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2008, 47 (01) : 1 - 6
  • [7] Renal Transplant Recipients and Patients With End Stage Renal Disease Present With More Advanced Bladder Cancer
    Ehdaie, Behfar
    Stukenborg, George J.
    Theodorescu, Dan
    JOURNAL OF UROLOGY, 2009, 182 (04) : 1482 - 1487
  • [8] Perioperative Outcomes of Laparoscopic Radical Nephrectomy for Renal Cell Carcinoma in Patients With Dialysis-Dependent End-Stage Renal Disease
    Yamashita, Kaori
    Ito, Fumio
    Nakazawa, Hayakazu
    THERAPEUTIC APHERESIS AND DIALYSIS, 2012, 16 (03) : 254 - 259
  • [9] Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma and End-stage Renal Disease at 2 Centers
    Tachibana, Hidekazu
    Kondo, Tsunenori
    Ishihara, Hiroki
    Takagi, Toshio
    Tanabe, Kazunari
    CLINICAL GENITOURINARY CANCER, 2019, 17 (04) : E772 - E778
  • [10] Renal Cell Carcinoma in End-Stage Kidney Disease and the Role of Transplantation
    Robinson, Samuel
    Nag, Alena
    Peticca, Benjamin
    Prudencio, Tomas
    Di Carlo, Antonio
    Karhadkar, Sunil
    CANCERS, 2024, 16 (01)